>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
脂肪细胞因子与眼部新生血管性疾病
作者:李芸芸1  栾洁2 
单位:1. 东南大学 医学院, 江苏 南京 210009;
2. 东南大学附属中大医院 眼科, 江苏 南京 210009
关键词:眼部新生血管 肥胖 脂肪细胞因子 代谢综合征 综述 
分类号:R771.3
出版年·卷·期(页码):2013·32·第三期(380-383)
摘要:

眼内新生血管性疾病一直是眼科的疑难杂症。新生血管生成促进因子与抑制因子之间的不平衡是眼内新生血管形成的主要原因。尽管抗VEGF(vascular endothelial growth factor,VEGF)药物的使用使得一部分患者视力有了明显改善,但仍有许多患者对抗VEGF治疗并无强烈反应。近年发现肥胖相关的脂肪细胞因子在眼部新生血管性疾病中扮演了重要角色。作者对与新生血管性眼病相关的脂肪细胞因子的研究进展作一综述。

参考文献:

[1] SUGANAMI E,TAKAGI H,OHASHI H.Leptin stimulates ischemia- induces retinal neovascularization[J].Diabetes,2004,53(9):2443-2448.
[2] TILG H,MOSCHEN A R.Role of adiponectin and PBEF/visfatin as regulators of inflammation:involvement in obesity-associated diseases[J].Clin Sci (Lond),2008,114(4):275-288.
[3] ZHANG Y,SCARPACE P J.The role of leptin resistance and obesity[J].Physiol Behav,2006,88(3):249-256.
[4] SARI R,BALCI M K,APAYDIN C.The relationship between leptin levels and chronic complication in patients with type 2 diabetes mellitus[J].Metab Syndr Relat Disord,2010,8(6):499-503.
[5] YAMAGISHI S,INAGAKI Y,NAKAMURA K,et a1.Pigment epithelium—derived factor inhibits TNF-a-induced intcrleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen specise generation[J].Mol Cell Cardiol,2004,37(4):497-506.
[6] CAO R,BRAKENHIELM E,WAHLESTEDT C,et al.Leptin induces vascular permeability and synergistically stimulates angeogenesis with FGF-2 and VEGF[J].Proc Natl Acad Sci USA,2001,98(11):6390-6395.
[7] RICKER L J,KIJLSTRA A.Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment[J].Exp Eye Res,2012,94(1):56-62.
[8] ORHAN A,MUSTAFA K,HABIP B,et al.Increased derum levels of leptin in retinal vein occlusion[J].Tohoku J Exp Med,2008,215(4):373-376.
[9] MABERLEY D,CUI J Z,MATSUBARA J A,et al.Vitreous leptin levels in retinal disease[J].Eye (Lond),2006,20(7):801-804.
[10] KOERNER A,KRATZSCH J,KIESS W,et al.Adipocytokines:leptin—the classical,resistin—the controversical,adiponectin—the promising,and more to come[J].Best Pract Res Clin Endocrinol Metab,2005,19(4):525-546.
[11] MATSUZAWA Y,FUNAHASHI T,KIHARA S,et al.Adiponectin and metabolic syndrome[J].Arterioscler Thromb Vasc Biol,2004,24(1):29-33.
[12] TILG H,MOSCHEN A R.Role of adiponectin and PBEF/visfatin as regulators of inflammation:involvement in obesity-associated diseases[J].Clin Sci (Lond),2008,114(4):275-288.
[13] MAO D,PENG H,LI Q,et al.Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients[J].Curr Eye Res,2012,37(9):803-808.
[14] BRÅKENHIELM E,VEITONMÄKI N,CAO R,et al.Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis[J].Proc Natl Acad Sci USA,2004,101(8):2476-2481.
[15] ADYA R,TAN B K,CHEN J,et al.Protective actions of globular and full-length adiponectin on human endothelial cells:novel insights into adiponectin-induced angiogenesis[J].J Vasc Res,2012,49(6):534-543.
[16] di SIMONE N,di NICUOLO F,SANGUINETTI M,et al.Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes[J].J Endocrinol,2006,189(3):691-699.
[17] FUKUHARA A,MATSUDA M,NISHIZAWA M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307(5708):426-430.
[18] KIM S R,BAE S K,CHOI K S,et al.Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2[J].Biochem Biophys Res Commun,2007,357(1):150-156.
[19] ADYA R,TAN B K,PUNN A,et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis[J].Cardiovasc Res,2008,78(2):356-365.
[20] BAE Y H,BAE M K,KIM S R,et al.Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis[J].Biochem Biophys Res Commun,2009,379(2):206-211.
[21] LOVREN F,PAN Y,SHUKLA P C,et al.Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo:translational implications for atherosclerosis[J].Am J Physiol Endocrinol Metab,2009,296(6):E1440-1449.
[22] KIM J Y,BAE Y H,BAE M K,et al.Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis[J].Biochim Biophys Acta,2009,1793(11):1759-1767.
[23] PARK J W,KIM W H,SHIN S H,et al.Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway[J].Biochim Biophys Acta,2011,1813(5):763-771.
[24] INOKI K,CORRADETTI M N,GUAN K L.Dysregulation of the TSC-mTOR pathway in human disease[J].Nat Genet,2005,37(1):19-24.
[25] TAKAHASHI-YANAGA F,SASAGURI T.GSK-3β regulates cyclin D1 expression:a new target for chemotherapy[J].Cell Signal,2008,20(4):581-589.
[26] ADYA R,TAN B K,PUNN A,et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signaling pathways:novel insights into visfatin-induced angiogenesis[J].Cardiovasc Res,2008,78(2):356-365.
[27] KIM S R,JUNG Y H,PARK H J,et al.Upregulation of thromboxane synthase mediates visfatin-induced interleukin-8 expression and angiogenic activity in endothelial cells[J].Biochem Biophys Res Commun,2012,418(4):662-668.
[28] KIM S R,BAE Y H,BAE S K,et al.Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells[J].Biochim Biophys Acta,2008,1783(5):886-895.
[29] BALAGOPAL P,GRAHAM T E,KAHN B B,et al.Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention:association with subclinical inflammation[J].J Clin Endocrinol Metab,2007,92(5):1971-1974.
[30] LI Z Z,LU X Z,LIU J B,et al.Serum retinol-binding protein 4 levels in patients with diabetic retinopathy[J].Int Med Res,2010,38(1):95-99.
[31] NAKAJIMA H,NAKAJIMA K,TARUTANI M,et al.The role of pigment epithelium-derived factor as an adipokine in psoriasis[J].Arch Dermatol Res,2012,304(1):81-84.
[32] NITHYAKALYANI M,FINNY M,MUTHUSWAMY B,et al.Imbalanced levels of angiogenic and angiostatic factors in vitreous,plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy[J].J Diabetes Complications,2012,26(5):435-441.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405614 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364